Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update

Low Serum Progranulin Predicts the Presence of Mutations: A Prospective Study

(2017) Emma C. Schofield et al.   JOURNAL OF ALZHEIMERS DISEASE

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies

(2016) Nicolas R. Barthélemy et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

(2016) Julio C. Rojas et al.   Annals of Clinical and Translational Neurology

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study

(2015) Michael Ewers et al.   Alzheimers & Dementia

Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis

(2015) Patrick Weydt et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives

(2015) Patrick Oeckl et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia

(2015) Tobias Skillbäck et al.   BRAIN

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Patients with Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis with the C9ORF72 Repeat Expansion

(2015) Anna K�m�l�inen et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

(2015) Ahmed Abdelhak et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD

(2015) Emily Feneberg et al.   JOURNAL OF NEURAL TRANSMISSION

Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration

(2015) Aiko Ishiki et al.   JOURNAL OF NEUROCHEMISTRY

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

(2015) N K Magdalinou et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease

(2015) Inês Baldeiras et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Lewy body dementias

(2015) Zuzana Walker et al.   LANCET

Frontotemporal dementia

(2015) Jee Bang et al.   LANCET

Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer's disease patients are unchanged

(2015) Nienke M. Timmer et al.   NEUROBIOLOGY OF AGING

Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration

(2015) Linda Gibbons et al.   NEUROBIOLOGY OF AGING

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

(2015) C.-H. Lu et al.   NEUROLOGY

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

(2015) David C. Bäckström et al.   JAMA Neurology

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

(2015) Megan K. Herbert et al.   Frontiers in Neurology

Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis

(2015) Hanne Struyfs et al.   Frontiers in Neurology

Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS

(2014) Janis Bennion Callister et al.   EXPERIMENTAL NEUROLOGY

Does CSF p-tau181 help to discriminate Alzheimer’s disease from other dementias and mild cognitive impairment? A meta-analysis of the literature

(2014) Wei Tang et al.   JOURNAL OF NEURAL TRANSMISSION

Divergent CSF   alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy

(2014) D. Wagshal et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Intact Protein Analysis of Ubiquitin in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Differences in Alzheimer’s Disease and Frontotemporal Lobar Degeneration

(2014) Patrick Oeckl et al.   JOURNAL OF PROTEOME RESEARCH

Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: A meta-analysis of 50 studies

(2014) Wei Tang et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

(2014) T. Skillback et al.   NEUROLOGY

Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS

(2014) Zhaoming Su et al.   NEURON

Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis

(2014) Stefan Lehnert et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia

(2014) Barbara Borroni et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

(2013) Carole S. Scherling et al.   ANNALS OF NEUROLOGY

Two Distinct Amnesic Profiles in Behavioral Variant Frontotemporal Dementia

(2013) Maxime Bertoux et al.   BIOLOGICAL PSYCHIATRY

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

(2013) Maria Landqvist Waldö et al.   BMC Neurology

“Prion-Like” Templated Misfolding in Tauopathies

(2013) Florence Clavaguera et al.   BRAIN PATHOLOGY

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

(2013) M. Suarez-Calvet et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The glial marker YKL-40 is decreased in synucleinopathies

(2013) Bob Olsson et al.   MOVEMENT DISORDERS

Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP

(2013) W. T. Hu et al.   NEUROLOGY

Criteria for the diagnosis of corticobasal degeneration

(2013) M. J. Armstrong et al.   NEUROLOGY

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease

(2013) David J. Irwin et al.   Frontiers in Aging Neuroscience

Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism

(2013) Rodolfo Savica et al.   JAMA Neurology

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

Frontotemporal Lobar Degeneration

(2012) Rachel E. Seltman et al.   CNS DRUGS

Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions ofC9ORF72

(2012) Azza Ismail et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

(2011) Lucilla Parnetti et al.   MOVEMENT DISORDERS

CSF metabolites in the differential diagnosis of Alzheimer’s disease from frontal variant of frontotemporal dementia

(2011) Francesca de Rino et al.   NEUROLOGICAL SCIENCES

CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease

(2011) R. Perneczky et al.   NEUROLOGY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes

(2011) Sara Bech et al.   PARKINSONISM & RELATED DISORDERS

Frontotemporal Lobar Degeneration

(2010) Gil D. Rabinovici et al.   CNS DRUGS

Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-β38/40/42 in Frontotemporal Dementias and Primary Progressive Aphasias

(2010) Mirko Bibl et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias

(2010) L. C. de Souza et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Microglial Upregulation of Progranulin as a Marker of Motor Neuron Degeneration

(2010) Thomas Philips et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

rs5848 polymorphism and serum progranulin level

(2010) Ging-Yuek R. Hsiung et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes

(2010) Sigurd D. Süssmuth et al.   MOVEMENT DISORDERS

Diagnostic Value of CSF Biomarker Profile in Frontotemporal Lobar Degeneration

(2009) Elisabeth Kapaki et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI

(2009) Y. Zhang et al.   BRAIN

Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disorders

(2009) Radu Constantinescu et al.   PARKINSONISM & RELATED DISORDERS

Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival

(2008) Philip Van Damme et al.   JOURNAL OF CELL BIOLOGY

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration

(2008) R. Ghidoni et al.   NEUROLOGY

CSF biomarkers in frontotemporal lobar degeneration with known pathology

(2008) H. Bian et al.   NEUROLOGY